[1]
“The Efficacy and Adverse Effects of SORAFENIB in patiants of Hepatocellular Carcinoma in AL-Beiruny University Hospital”, Tuj-hlth, vol. 43, no. 5, Oct. 2021, Accessed: Nov. 02, 2026. Available: https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/11001